Nicklas Westerholm
Vorstandsvorsitzender bei EGETIS THERAPEUTICS AB
Vermögen: 114 876 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Nicklas Westerholm
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
41
| Subsidiary | Miscellaneous Commercial Services | 41 |
Public Company | Pharmaceuticals: Major | 25 | |
Public Company | Biotechnology | 11 | |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden.
2
| Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicklas Westerholm
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Director of Finance/CFO Public Communications Contact Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Compliance Officer | |
GALAPAGOS NV | Biotechnology | Director of Finance/CFO Director/Board Member | |
ACTIVE BIOTECH AB | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Karolinska Institutet Holding AB
Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
OREXO AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Chairman Director/Board Member | |
Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman General Counsel | |
University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Melacure Therapeutics AB
Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Melacure Therapeutics AB develops and manufactures pharmaceutical products. Its products are used for treatment of obesity, irritable bowel syndrome, inflammation, and sexual dysfunction. The company was founded in 1998 and is located in Uppsala, Sweden. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
University of Lund | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Umea Universitet | College/University | Corporate Officer/Principal Graduate Degree | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Astra Pharmaceuticals LP | Corporate Officer/Principal Corporate Officer/Principal | ||
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
Astra Hässle AB | Chief Executive Officer Director/Board Member | ||
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Recipharm Stockholm AB | Director/Board Member Chairman Director/Board Member | ||
Recipharm Strängnäs AB
Recipharm Strängnäs AB Miscellaneous Commercial ServicesCommercial Services Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Recipharm Karlskoga AB
Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Karlskoga AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Chairman | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal Chief Operating Officer Director/Board Member | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Chairman Corporate Officer/Principal | |
Swedish Pharmaceutical Society | Chairman Chairman | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal Chairman | ||
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chairman Founder | |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Recipharm Höganäs AB | Biotechnology | Director/Board Member Chairman | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
DICOT PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Forska Sverige
Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistik
International
Schweden | 43 |
Vereinigte Staaten | 4 |
Dänemark | 3 |
Vereinigtes Königreich | 2 |
Belgien | 2 |
Sektoral
Health Technology | 28 |
Consumer Services | 9 |
Commercial Services | 6 |
Miscellaneous | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 275 |
Corporate Officer/Principal | 154 |
Chief Executive Officer | 71 |
Chairman | 65 |
Independent Dir/Board Member | 50 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nicklas Westerholm
- Unternehmensverbindungen